Global Blood Glucose Testing research
Global Blood Glucose Testing research

Blood Glucose Testing Comprehensive Study by Type (Fingertip Testing, Alternate Site Testing), Application (Self/Home Care, Hospital & Clinics), Product (Blood Glucose Meters, Continuous Glucose Monitoring Systems {Sensors, Transmitter}, Glucose Monitoring Strips, Lancets), Diabetes (Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes) Players and Region - Global Market Outlook to 2024

Blood Glucose Testing Market Segmented into XX Submarkets. | Forecast Years: 2019- 2024  

Jan 2020 Edition 201 Pages 172 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Blood Glucose Testing Market Scope
Blood glucose testing is the procedure that is used to measure the concentration of glucose in the blood. Blood glucose testing can be carried out anywhere at home using a blood glucose meter. Basically glucose is a simple sugar which is considered as one of the main sources of energy. The human body converts the carbohydrates whatever they eat into glucose. There are different types of tests to check diabetes, where diabetes can cause because of the rise in the level of glucose in the body. I few cases the test happens with the use of hypoglycemia.

The market study is being classified by Type (Fingertip Testing and Alternate Site Testing), by Application (Self/Home Care and Hospital & Clinics) and major geographies with country level break-up.

The global blood glucose testing market is highly competitive and consists of some key players. In terms of market share, few of the key players presently dominate the global market. These market players are leveraging on strategic collaborative creativities to intensification their market share and escalation their profitability. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Blood Glucose Testing market throughout the predicted period.

American Diabetes Association (United States), Menarini Diagnostics (Italy), Abaxis (United States), Abbott Laboratories (United States), ACON Laboratories, Inc. (United States), AgaMatrix (Germany), Bayer (Germany), Bio-Rad (United States), Roche (Switzerland) and LifeScan (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Ascensia (Switzerland), Medtronic (Ireland), Dexcom (United States), Ypsomed (Switzerland) and B. Braun (Germany).

Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global Blood Glucose Testing market by Type, Application and Region.

On the basis of geography, the market of Blood Glucose Testing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Market Trend
  • High adoption in United States regions because of the increasing number of diabetes patients
  • Technology advancement in glucose monitoring devices

Market Drivers
  • Growing Prevalence of Diabetes
  • Increasing Number of Product Launches

Opportunities
  • Pipeline Products and Ongoing Research - There is technology advancement in products and continuous investment by the leading players. With the increasing number of healthcare centers and laboratories across the developed regions.

Restraints
  • High Cost and Poor Reimbursement associated with Blood Glucose Monitoring Systems and its product Supplies

Challenges
  • Invasiveness of Blood Glucose Monitors


Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Blood Glucose Testing Service Providers, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase
Report Objectives / Segmentation Covered
By Type
  • Fingertip Testing
  • Alternate Site Testing
By Application
  • Self/Home Care
  • Hospital & Clinics
By Product
  • Blood Glucose Meters
  • Continuous Glucose Monitoring Systems {Sensors, Transmitter}
  • Glucose Monitoring Strips
  • Lancets

By Diabetes
  • Type 2 Diabetes
  • Type 1 Diabetes
  • Gestational Diabetes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Prevalence of Diabetes
      • 3.2.2. Increasing Number of Product Launches
    • 3.3. Market Challenges
      • 3.3.1. Invasiveness of Blood Glucose Monitors
    • 3.4. Market Trends
      • 3.4.1. High adoption in United States regions because of the increasing number of diabetes patients
      • 3.4.2. Technology advancement in glucose monitoring devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Blood Glucose Testing, by Type, Application, Product, Diabetes and Region (value, volume and price ) (2013-2018)
    • 5.1. Introduction
    • 5.2. Global Blood Glucose Testing (Value)
      • 5.2.1. Global Blood Glucose Testing by: Type (Value)
        • 5.2.1.1. Fingertip Testing
        • 5.2.1.2. Alternate Site Testing
      • 5.2.2. Global Blood Glucose Testing by: Application (Value)
        • 5.2.2.1. Self/Home Care
        • 5.2.2.2. Hospital & Clinics
      • 5.2.3. Global Blood Glucose Testing by: Product (Value)
        • 5.2.3.1. Blood Glucose Meters
        • 5.2.3.2. Continuous Glucose Monitoring Systems {Sensors, Transmitter}
        • 5.2.3.3. Glucose Monitoring Strips
        • 5.2.3.4. Lancets
      • 5.2.4. Global Blood Glucose Testing by: Diabetes (Value)
        • 5.2.4.1. Type 2 Diabetes
        • 5.2.4.2. Type 1 Diabetes
        • 5.2.4.3. Gestational Diabetes
      • 5.2.5. Global Blood Glucose Testing Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Blood Glucose Testing (Volume)
      • 5.3.1. Global Blood Glucose Testing by: Type (Volume)
        • 5.3.1.1. Fingertip Testing
        • 5.3.1.2. Alternate Site Testing
      • 5.3.2. Global Blood Glucose Testing by: Application (Volume)
        • 5.3.2.1. Self/Home Care
        • 5.3.2.2. Hospital & Clinics
      • 5.3.3. Global Blood Glucose Testing by: Product (Volume)
        • 5.3.3.1. Blood Glucose Meters
        • 5.3.3.2. Continuous Glucose Monitoring Systems {Sensors, Transmitter}
        • 5.3.3.3. Glucose Monitoring Strips
        • 5.3.3.4. Lancets
      • 5.3.4. Global Blood Glucose Testing by: Diabetes (Volume)
        • 5.3.4.1. Type 2 Diabetes
        • 5.3.4.2. Type 1 Diabetes
        • 5.3.4.3. Gestational Diabetes
      • 5.3.5. Global Blood Glucose Testing Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Blood Glucose Testing (Price)
      • 5.4.1. Global Blood Glucose Testing by: Type (Price)
  • 6. Blood Glucose Testing: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2018)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. American Diabetes Association (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Menarini Diagnostics (Italy)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Abaxis (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Abbott Laboratories (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. ACON Laboratories, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. AgaMatrix (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Bayer (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Bio-Rad (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Roche (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. LifeScan (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Blood Glucose Testing Sale, by Type, Application, Product, Diabetes and Region (value, volume and price ) (2019-2024)
    • 7.1. Introduction
    • 7.2. Global Blood Glucose Testing (Value)
      • 7.2.1. Global Blood Glucose Testing by: Type (Value)
        • 7.2.1.1. Fingertip Testing
        • 7.2.1.2. Alternate Site Testing
      • 7.2.2. Global Blood Glucose Testing by: Application (Value)
        • 7.2.2.1. Self/Home Care
        • 7.2.2.2. Hospital & Clinics
      • 7.2.3. Global Blood Glucose Testing by: Product (Value)
        • 7.2.3.1. Blood Glucose Meters
        • 7.2.3.2. Continuous Glucose Monitoring Systems {Sensors, Transmitter}
        • 7.2.3.3. Glucose Monitoring Strips
        • 7.2.3.4. Lancets
      • 7.2.4. Global Blood Glucose Testing by: Diabetes (Value)
        • 7.2.4.1. Type 2 Diabetes
        • 7.2.4.2. Type 1 Diabetes
        • 7.2.4.3. Gestational Diabetes
      • 7.2.5. Global Blood Glucose Testing Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Blood Glucose Testing (Volume)
      • 7.3.1. Global Blood Glucose Testing by: Type (Volume)
        • 7.3.1.1. Fingertip Testing
        • 7.3.1.2. Alternate Site Testing
      • 7.3.2. Global Blood Glucose Testing by: Application (Volume)
        • 7.3.2.1. Self/Home Care
        • 7.3.2.2. Hospital & Clinics
      • 7.3.3. Global Blood Glucose Testing by: Product (Volume)
        • 7.3.3.1. Blood Glucose Meters
        • 7.3.3.2. Continuous Glucose Monitoring Systems {Sensors, Transmitter}
        • 7.3.3.3. Glucose Monitoring Strips
        • 7.3.3.4. Lancets
      • 7.3.4. Global Blood Glucose Testing by: Diabetes (Volume)
        • 7.3.4.1. Type 2 Diabetes
        • 7.3.4.2. Type 1 Diabetes
        • 7.3.4.3. Gestational Diabetes
      • 7.3.5. Global Blood Glucose Testing Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Blood Glucose Testing (Price)
      • 7.4.1. Global Blood Glucose Testing by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Blood Glucose Testing: by Type(USD Million)
  • Table 2. Blood Glucose Testing Fingertip Testing , by Region USD Million (2013-2018)
  • Table 3. Blood Glucose Testing Alternate Site Testing , by Region USD Million (2013-2018)
  • Table 4. Blood Glucose Testing: by Application(USD Million)
  • Table 5. Blood Glucose Testing Self/Home Care , by Region USD Million (2013-2018)
  • Table 6. Blood Glucose Testing Hospital & Clinics , by Region USD Million (2013-2018)
  • Table 7. Blood Glucose Testing: by Product(USD Million)
  • Table 8. Blood Glucose Testing Blood Glucose Meters , by Region USD Million (2013-2018)
  • Table 9. Blood Glucose Testing Continuous Glucose Monitoring Systems {Sensors, Transmitter} , by Region USD Million (2013-2018)
  • Table 10. Blood Glucose Testing Glucose Monitoring Strips , by Region USD Million (2013-2018)
  • Table 11. Blood Glucose Testing Lancets , by Region USD Million (2013-2018)
  • Table 12. Blood Glucose Testing: by Diabetes(USD Million)
  • Table 13. Blood Glucose Testing Type 2 Diabetes , by Region USD Million (2013-2018)
  • Table 14. Blood Glucose Testing Type 1 Diabetes , by Region USD Million (2013-2018)
  • Table 15. Blood Glucose Testing Gestational Diabetes , by Region USD Million (2013-2018)
  • Table 16. South America Blood Glucose Testing, by Country USD Million (2013-2018)
  • Table 17. South America Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 18. South America Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 19. South America Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 20. South America Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 21. Brazil Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 22. Brazil Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 23. Brazil Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 24. Brazil Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 25. Argentina Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 26. Argentina Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 27. Argentina Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 28. Argentina Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 29. Rest of South America Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 30. Rest of South America Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 31. Rest of South America Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 32. Rest of South America Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 33. Asia Pacific Blood Glucose Testing, by Country USD Million (2013-2018)
  • Table 34. Asia Pacific Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 35. Asia Pacific Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 36. Asia Pacific Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 37. Asia Pacific Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 38. China Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 39. China Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 40. China Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 41. China Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 42. Japan Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 43. Japan Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 44. Japan Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 45. Japan Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 46. India Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 47. India Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 48. India Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 49. India Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 50. South Korea Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 51. South Korea Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 52. South Korea Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 53. South Korea Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 54. Taiwan Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 55. Taiwan Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 56. Taiwan Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 57. Taiwan Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 58. Australia Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 59. Australia Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 60. Australia Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 61. Australia Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 62. Rest of Asia-Pacific Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 63. Rest of Asia-Pacific Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 64. Rest of Asia-Pacific Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 65. Rest of Asia-Pacific Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 66. Europe Blood Glucose Testing, by Country USD Million (2013-2018)
  • Table 67. Europe Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 68. Europe Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 69. Europe Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 70. Europe Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 71. Germany Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 72. Germany Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 73. Germany Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 74. Germany Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 75. France Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 76. France Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 77. France Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 78. France Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 79. Italy Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 80. Italy Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 81. Italy Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 82. Italy Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 83. United Kingdom Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 84. United Kingdom Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 85. United Kingdom Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 86. United Kingdom Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 87. Netherlands Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 88. Netherlands Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 89. Netherlands Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 90. Netherlands Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 91. Rest of Europe Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 92. Rest of Europe Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 93. Rest of Europe Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 94. Rest of Europe Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 95. MEA Blood Glucose Testing, by Country USD Million (2013-2018)
  • Table 96. MEA Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 97. MEA Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 98. MEA Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 99. MEA Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 100. Middle East Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 101. Middle East Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 102. Middle East Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 103. Middle East Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 104. Africa Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 105. Africa Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 106. Africa Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 107. Africa Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 108. North America Blood Glucose Testing, by Country USD Million (2013-2018)
  • Table 109. North America Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 110. North America Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 111. North America Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 112. North America Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 113. United States Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 114. United States Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 115. United States Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 116. United States Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 117. Canada Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 118. Canada Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 119. Canada Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 120. Canada Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 121. Mexico Blood Glucose Testing, by Type USD Million (2013-2018)
  • Table 122. Mexico Blood Glucose Testing, by Application USD Million (2013-2018)
  • Table 123. Mexico Blood Glucose Testing, by Product USD Million (2013-2018)
  • Table 124. Mexico Blood Glucose Testing, by Diabetes USD Million (2013-2018)
  • Table 125. Blood Glucose Testing Sales: by Type(K Units)
  • Table 126. Blood Glucose Testing Sales Fingertip Testing , by Region K Units (2013-2018)
  • Table 127. Blood Glucose Testing Sales Alternate Site Testing , by Region K Units (2013-2018)
  • Table 128. Blood Glucose Testing Sales: by Application(K Units)
  • Table 129. Blood Glucose Testing Sales Self/Home Care , by Region K Units (2013-2018)
  • Table 130. Blood Glucose Testing Sales Hospital & Clinics , by Region K Units (2013-2018)
  • Table 131. Blood Glucose Testing Sales: by Product(K Units)
  • Table 132. Blood Glucose Testing Sales Blood Glucose Meters , by Region K Units (2013-2018)
  • Table 133. Blood Glucose Testing Sales Continuous Glucose Monitoring Systems {Sensors, Transmitter} , by Region K Units (2013-2018)
  • Table 134. Blood Glucose Testing Sales Glucose Monitoring Strips , by Region K Units (2013-2018)
  • Table 135. Blood Glucose Testing Sales Lancets , by Region K Units (2013-2018)
  • Table 136. Blood Glucose Testing Sales: by Diabetes(K Units)
  • Table 137. Blood Glucose Testing Sales Type 2 Diabetes , by Region K Units (2013-2018)
  • Table 138. Blood Glucose Testing Sales Type 1 Diabetes , by Region K Units (2013-2018)
  • Table 139. Blood Glucose Testing Sales Gestational Diabetes , by Region K Units (2013-2018)
  • Table 140. South America Blood Glucose Testing Sales, by Country K Units (2013-2018)
  • Table 141. South America Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 142. South America Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 143. South America Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 144. South America Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 145. Brazil Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 146. Brazil Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 147. Brazil Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 148. Brazil Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 149. Argentina Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 150. Argentina Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 151. Argentina Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 152. Argentina Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 153. Rest of South America Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 154. Rest of South America Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 155. Rest of South America Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 156. Rest of South America Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 157. Asia Pacific Blood Glucose Testing Sales, by Country K Units (2013-2018)
  • Table 158. Asia Pacific Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 159. Asia Pacific Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 160. Asia Pacific Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 161. Asia Pacific Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 162. China Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 163. China Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 164. China Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 165. China Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 166. Japan Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 167. Japan Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 168. Japan Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 169. Japan Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 170. India Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 171. India Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 172. India Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 173. India Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 174. South Korea Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 175. South Korea Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 176. South Korea Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 177. South Korea Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 178. Taiwan Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 179. Taiwan Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 180. Taiwan Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 181. Taiwan Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 182. Australia Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 183. Australia Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 184. Australia Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 185. Australia Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 186. Rest of Asia-Pacific Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 187. Rest of Asia-Pacific Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 188. Rest of Asia-Pacific Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 189. Rest of Asia-Pacific Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 190. Europe Blood Glucose Testing Sales, by Country K Units (2013-2018)
  • Table 191. Europe Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 192. Europe Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 193. Europe Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 194. Europe Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 195. Germany Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 196. Germany Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 197. Germany Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 198. Germany Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 199. France Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 200. France Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 201. France Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 202. France Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 203. Italy Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 204. Italy Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 205. Italy Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 206. Italy Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 207. United Kingdom Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 208. United Kingdom Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 209. United Kingdom Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 210. United Kingdom Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 211. Netherlands Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 212. Netherlands Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 213. Netherlands Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 214. Netherlands Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 215. Rest of Europe Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 216. Rest of Europe Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 217. Rest of Europe Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 218. Rest of Europe Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 219. MEA Blood Glucose Testing Sales, by Country K Units (2013-2018)
  • Table 220. MEA Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 221. MEA Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 222. MEA Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 223. MEA Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 224. Middle East Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 225. Middle East Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 226. Middle East Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 227. Middle East Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 228. Africa Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 229. Africa Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 230. Africa Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 231. Africa Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 232. North America Blood Glucose Testing Sales, by Country K Units (2013-2018)
  • Table 233. North America Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 234. North America Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 235. North America Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 236. North America Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 237. United States Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 238. United States Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 239. United States Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 240. United States Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 241. Canada Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 242. Canada Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 243. Canada Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 244. Canada Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 245. Mexico Blood Glucose Testing Sales, by Type K Units (2013-2018)
  • Table 246. Mexico Blood Glucose Testing Sales, by Application K Units (2013-2018)
  • Table 247. Mexico Blood Glucose Testing Sales, by Product K Units (2013-2018)
  • Table 248. Mexico Blood Glucose Testing Sales, by Diabetes K Units (2013-2018)
  • Table 249. Blood Glucose Testing: by Type(USD/Units)
  • Table 250. Company Basic Information, Sales Area and Its Competitors
  • Table 251. Company Basic Information, Sales Area and Its Competitors
  • Table 252. Company Basic Information, Sales Area and Its Competitors
  • Table 253. Company Basic Information, Sales Area and Its Competitors
  • Table 254. Company Basic Information, Sales Area and Its Competitors
  • Table 255. Company Basic Information, Sales Area and Its Competitors
  • Table 256. Company Basic Information, Sales Area and Its Competitors
  • Table 257. Company Basic Information, Sales Area and Its Competitors
  • Table 258. Company Basic Information, Sales Area and Its Competitors
  • Table 259. Company Basic Information, Sales Area and Its Competitors
  • Table 260. Blood Glucose Testing: by Type(USD Million)
  • Table 261. Blood Glucose Testing Fingertip Testing , by Region USD Million (2019-2024)
  • Table 262. Blood Glucose Testing Alternate Site Testing , by Region USD Million (2019-2024)
  • Table 263. Blood Glucose Testing: by Application(USD Million)
  • Table 264. Blood Glucose Testing Self/Home Care , by Region USD Million (2019-2024)
  • Table 265. Blood Glucose Testing Hospital & Clinics , by Region USD Million (2019-2024)
  • Table 266. Blood Glucose Testing: by Product(USD Million)
  • Table 267. Blood Glucose Testing Blood Glucose Meters , by Region USD Million (2019-2024)
  • Table 268. Blood Glucose Testing Continuous Glucose Monitoring Systems {Sensors, Transmitter} , by Region USD Million (2019-2024)
  • Table 269. Blood Glucose Testing Glucose Monitoring Strips , by Region USD Million (2019-2024)
  • Table 270. Blood Glucose Testing Lancets , by Region USD Million (2019-2024)
  • Table 271. Blood Glucose Testing: by Diabetes(USD Million)
  • Table 272. Blood Glucose Testing Type 2 Diabetes , by Region USD Million (2019-2024)
  • Table 273. Blood Glucose Testing Type 1 Diabetes , by Region USD Million (2019-2024)
  • Table 274. Blood Glucose Testing Gestational Diabetes , by Region USD Million (2019-2024)
  • Table 275. South America Blood Glucose Testing, by Country USD Million (2019-2024)
  • Table 276. South America Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 277. South America Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 278. South America Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 279. South America Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 280. Brazil Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 281. Brazil Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 282. Brazil Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 283. Brazil Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 284. Argentina Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 285. Argentina Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 286. Argentina Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 287. Argentina Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 288. Rest of South America Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 289. Rest of South America Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 290. Rest of South America Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 291. Rest of South America Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 292. Asia Pacific Blood Glucose Testing, by Country USD Million (2019-2024)
  • Table 293. Asia Pacific Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 294. Asia Pacific Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 295. Asia Pacific Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 296. Asia Pacific Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 297. China Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 298. China Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 299. China Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 300. China Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 301. Japan Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 302. Japan Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 303. Japan Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 304. Japan Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 305. India Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 306. India Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 307. India Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 308. India Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 309. South Korea Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 310. South Korea Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 311. South Korea Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 312. South Korea Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 313. Taiwan Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 314. Taiwan Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 315. Taiwan Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 316. Taiwan Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 317. Australia Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 318. Australia Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 319. Australia Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 320. Australia Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 321. Rest of Asia-Pacific Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 322. Rest of Asia-Pacific Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 323. Rest of Asia-Pacific Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 324. Rest of Asia-Pacific Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 325. Europe Blood Glucose Testing, by Country USD Million (2019-2024)
  • Table 326. Europe Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 327. Europe Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 328. Europe Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 329. Europe Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 330. Germany Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 331. Germany Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 332. Germany Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 333. Germany Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 334. France Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 335. France Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 336. France Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 337. France Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 338. Italy Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 339. Italy Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 340. Italy Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 341. Italy Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 342. United Kingdom Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 343. United Kingdom Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 344. United Kingdom Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 345. United Kingdom Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 346. Netherlands Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 347. Netherlands Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 348. Netherlands Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 349. Netherlands Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 350. Rest of Europe Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 351. Rest of Europe Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 352. Rest of Europe Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 353. Rest of Europe Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 354. MEA Blood Glucose Testing, by Country USD Million (2019-2024)
  • Table 355. MEA Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 356. MEA Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 357. MEA Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 358. MEA Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 359. Middle East Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 360. Middle East Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 361. Middle East Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 362. Middle East Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 363. Africa Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 364. Africa Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 365. Africa Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 366. Africa Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 367. North America Blood Glucose Testing, by Country USD Million (2019-2024)
  • Table 368. North America Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 369. North America Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 370. North America Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 371. North America Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 372. United States Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 373. United States Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 374. United States Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 375. United States Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 376. Canada Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 377. Canada Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 378. Canada Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 379. Canada Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 380. Mexico Blood Glucose Testing, by Type USD Million (2019-2024)
  • Table 381. Mexico Blood Glucose Testing, by Application USD Million (2019-2024)
  • Table 382. Mexico Blood Glucose Testing, by Product USD Million (2019-2024)
  • Table 383. Mexico Blood Glucose Testing, by Diabetes USD Million (2019-2024)
  • Table 384. Blood Glucose Testing Sales: by Type(K Units)
  • Table 385. Blood Glucose Testing Sales Fingertip Testing , by Region K Units (2019-2024)
  • Table 386. Blood Glucose Testing Sales Alternate Site Testing , by Region K Units (2019-2024)
  • Table 387. Blood Glucose Testing Sales: by Application(K Units)
  • Table 388. Blood Glucose Testing Sales Self/Home Care , by Region K Units (2019-2024)
  • Table 389. Blood Glucose Testing Sales Hospital & Clinics , by Region K Units (2019-2024)
  • Table 390. Blood Glucose Testing Sales: by Product(K Units)
  • Table 391. Blood Glucose Testing Sales Blood Glucose Meters , by Region K Units (2019-2024)
  • Table 392. Blood Glucose Testing Sales Continuous Glucose Monitoring Systems {Sensors, Transmitter} , by Region K Units (2019-2024)
  • Table 393. Blood Glucose Testing Sales Glucose Monitoring Strips , by Region K Units (2019-2024)
  • Table 394. Blood Glucose Testing Sales Lancets , by Region K Units (2019-2024)
  • Table 395. Blood Glucose Testing Sales: by Diabetes(K Units)
  • Table 396. Blood Glucose Testing Sales Type 2 Diabetes , by Region K Units (2019-2024)
  • Table 397. Blood Glucose Testing Sales Type 1 Diabetes , by Region K Units (2019-2024)
  • Table 398. Blood Glucose Testing Sales Gestational Diabetes , by Region K Units (2019-2024)
  • Table 399. South America Blood Glucose Testing Sales, by Country K Units (2019-2024)
  • Table 400. South America Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 401. South America Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 402. South America Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 403. South America Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 404. Brazil Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 405. Brazil Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 406. Brazil Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 407. Brazil Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 408. Argentina Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 409. Argentina Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 410. Argentina Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 411. Argentina Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 412. Rest of South America Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 413. Rest of South America Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 414. Rest of South America Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 415. Rest of South America Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 416. Asia Pacific Blood Glucose Testing Sales, by Country K Units (2019-2024)
  • Table 417. Asia Pacific Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 418. Asia Pacific Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 419. Asia Pacific Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 420. Asia Pacific Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 421. China Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 422. China Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 423. China Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 424. China Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 425. Japan Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 426. Japan Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 427. Japan Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 428. Japan Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 429. India Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 430. India Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 431. India Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 432. India Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 433. South Korea Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 434. South Korea Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 435. South Korea Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 436. South Korea Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 437. Taiwan Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 438. Taiwan Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 439. Taiwan Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 440. Taiwan Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 441. Australia Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 442. Australia Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 443. Australia Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 444. Australia Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 445. Rest of Asia-Pacific Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 446. Rest of Asia-Pacific Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 447. Rest of Asia-Pacific Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 448. Rest of Asia-Pacific Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 449. Europe Blood Glucose Testing Sales, by Country K Units (2019-2024)
  • Table 450. Europe Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 451. Europe Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 452. Europe Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 453. Europe Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 454. Germany Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 455. Germany Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 456. Germany Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 457. Germany Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 458. France Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 459. France Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 460. France Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 461. France Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 462. Italy Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 463. Italy Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 464. Italy Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 465. Italy Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 466. United Kingdom Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 467. United Kingdom Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 468. United Kingdom Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 469. United Kingdom Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 470. Netherlands Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 471. Netherlands Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 472. Netherlands Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 473. Netherlands Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 474. Rest of Europe Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 475. Rest of Europe Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 476. Rest of Europe Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 477. Rest of Europe Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 478. MEA Blood Glucose Testing Sales, by Country K Units (2019-2024)
  • Table 479. MEA Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 480. MEA Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 481. MEA Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 482. MEA Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 483. Middle East Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 484. Middle East Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 485. Middle East Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 486. Middle East Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 487. Africa Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 488. Africa Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 489. Africa Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 490. Africa Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 491. North America Blood Glucose Testing Sales, by Country K Units (2019-2024)
  • Table 492. North America Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 493. North America Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 494. North America Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 495. North America Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 496. United States Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 497. United States Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 498. United States Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 499. United States Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 500. Canada Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 501. Canada Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 502. Canada Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 503. Canada Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 504. Mexico Blood Glucose Testing Sales, by Type K Units (2019-2024)
  • Table 505. Mexico Blood Glucose Testing Sales, by Application K Units (2019-2024)
  • Table 506. Mexico Blood Glucose Testing Sales, by Product K Units (2019-2024)
  • Table 507. Mexico Blood Glucose Testing Sales, by Diabetes K Units (2019-2024)
  • Table 508. Blood Glucose Testing: by Type(USD/Units)
  • Table 509. Research Programs/Design for This Report
  • Table 510. Key Data Information from Secondary Sources
  • Table 511. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Blood Glucose Testing: by Type USD Million (2013-2018)
  • Figure 5. Global Blood Glucose Testing: by Application USD Million (2013-2018)
  • Figure 6. Global Blood Glucose Testing: by Product USD Million (2013-2018)
  • Figure 7. Global Blood Glucose Testing: by Diabetes USD Million (2013-2018)
  • Figure 8. South America Blood Glucose Testing Share (%), by Country
  • Figure 9. Asia Pacific Blood Glucose Testing Share (%), by Country
  • Figure 10. Europe Blood Glucose Testing Share (%), by Country
  • Figure 11. MEA Blood Glucose Testing Share (%), by Country
  • Figure 12. North America Blood Glucose Testing Share (%), by Country
  • Figure 13. Global Blood Glucose Testing: by Type K Units (2013-2018)
  • Figure 14. Global Blood Glucose Testing: by Application K Units (2013-2018)
  • Figure 15. Global Blood Glucose Testing: by Product K Units (2013-2018)
  • Figure 16. Global Blood Glucose Testing: by Diabetes K Units (2013-2018)
  • Figure 17. South America Blood Glucose Testing Share (%), by Country
  • Figure 18. Asia Pacific Blood Glucose Testing Share (%), by Country
  • Figure 19. Europe Blood Glucose Testing Share (%), by Country
  • Figure 20. MEA Blood Glucose Testing Share (%), by Country
  • Figure 21. North America Blood Glucose Testing Share (%), by Country
  • Figure 22. Global Blood Glucose Testing: by Type USD/Units (2013-2018)
  • Figure 23. Global Blood Glucose Testing share by Players 2018 (%)
  • Figure 24. Global Blood Glucose Testing share by Players (Top 3) 2018(%)
  • Figure 25. Global Blood Glucose Testing share by Players (Top 5) 2018(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. American Diabetes Association (United States) Revenue, Net Income and Gross profit
  • Figure 28. American Diabetes Association (United States) Revenue: by Geography 2018
  • Figure 29. Menarini Diagnostics (Italy) Revenue, Net Income and Gross profit
  • Figure 30. Menarini Diagnostics (Italy) Revenue: by Geography 2018
  • Figure 31. Abaxis (United States) Revenue, Net Income and Gross profit
  • Figure 32. Abaxis (United States) Revenue: by Geography 2018
  • Figure 33. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 34. Abbott Laboratories (United States) Revenue: by Geography 2018
  • Figure 35. ACON Laboratories, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. ACON Laboratories, Inc. (United States) Revenue: by Geography 2018
  • Figure 37. AgaMatrix (Germany) Revenue, Net Income and Gross profit
  • Figure 38. AgaMatrix (Germany) Revenue: by Geography 2018
  • Figure 39. Bayer (Germany) Revenue, Net Income and Gross profit
  • Figure 40. Bayer (Germany) Revenue: by Geography 2018
  • Figure 41. Bio-Rad (United States) Revenue, Net Income and Gross profit
  • Figure 42. Bio-Rad (United States) Revenue: by Geography 2018
  • Figure 43. Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 44. Roche (Switzerland) Revenue: by Geography 2018
  • Figure 45. LifeScan (United States) Revenue, Net Income and Gross profit
  • Figure 46. LifeScan (United States) Revenue: by Geography 2018
  • Figure 47. Global Blood Glucose Testing: by Type USD Million (2019-2024)
  • Figure 48. Global Blood Glucose Testing: by Application USD Million (2019-2024)
  • Figure 49. Global Blood Glucose Testing: by Product USD Million (2019-2024)
  • Figure 50. Global Blood Glucose Testing: by Diabetes USD Million (2019-2024)
  • Figure 51. South America Blood Glucose Testing Share (%), by Country
  • Figure 52. Asia Pacific Blood Glucose Testing Share (%), by Country
  • Figure 53. Europe Blood Glucose Testing Share (%), by Country
  • Figure 54. MEA Blood Glucose Testing Share (%), by Country
  • Figure 55. North America Blood Glucose Testing Share (%), by Country
  • Figure 56. Global Blood Glucose Testing: by Type K Units (2019-2024)
  • Figure 57. Global Blood Glucose Testing: by Application K Units (2019-2024)
  • Figure 58. Global Blood Glucose Testing: by Product K Units (2019-2024)
  • Figure 59. Global Blood Glucose Testing: by Diabetes K Units (2019-2024)
  • Figure 60. South America Blood Glucose Testing Share (%), by Country
  • Figure 61. Asia Pacific Blood Glucose Testing Share (%), by Country
  • Figure 62. Europe Blood Glucose Testing Share (%), by Country
  • Figure 63. MEA Blood Glucose Testing Share (%), by Country
  • Figure 64. North America Blood Glucose Testing Share (%), by Country
  • Figure 65. Global Blood Glucose Testing: by Type USD/Units (2019-2024)
Some of the key companies/manufacturers profiled in the report
  • American Diabetes Association (United States)
  • Menarini Diagnostics (Italy)
  • Abaxis (United States)
  • Abbott Laboratories (United States)
  • ACON Laboratories, Inc. (United States)
  • AgaMatrix (Germany)
  • Bayer (Germany)
  • Bio-Rad (United States)
  • Roche (Switzerland)
  • LifeScan (United States)
Additional players considered in the study are as follows:
Ascensia (Switzerland) , Medtronic (Ireland) , Dexcom (United States) , Ypsomed (Switzerland) , B. Braun (Germany)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation